Economics of antiretroviral treatment vs. circumcision for HIV prevention
The HIV Prevention Trials Network (HPTN) 052 study, which showed the effectiveness of antiretroviral treatment in reducing HIV transmission, has been hailed as a “game changer” in the fight against HIV, prompting calls for scaling up treatment as prevention (TasP). However, it is unclear how TasP ca...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
December 26, 2012
|
| In: |
Proceedings of the National Academy of Sciences of the United States of America
Year: 2012, Jahrgang: 109, Heft: 52, Pages: 21271-21276 |
| ISSN: | 1091-6490 |
| DOI: | 10.1073/pnas.1209017110 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1073/pnas.1209017110 Verlag, kostenfrei, Volltext: https://www.pnas.org/doi/full/10.1073/pnas.1209017110 
|
| Verfasserangaben: | Till Bärnighausen, David E. Bloom, and Salal Humair |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1559096527 | ||
| 003 | DE-627 | ||
| 005 | 20241010094525.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 170530s2012 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1073/pnas.1209017110 |2 doi | |
| 035 | |a (DE-627)1559096527 | ||
| 035 | |a (DE-576)489096522 | ||
| 035 | |a (DE-599)BSZ489096522 | ||
| 035 | |a (OCoLC)1340975804 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Bärnighausen, Till |d 1969- |e VerfasserIn |0 (DE-588)120262029 |0 (DE-627)080560512 |0 (DE-576)178470848 |4 aut | |
| 245 | 1 | 0 | |a Economics of antiretroviral treatment vs. circumcision for HIV prevention |c Till Bärnighausen, David E. Bloom, and Salal Humair |
| 264 | 1 | |c December 26, 2012 | |
| 300 | |a 6 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 30.05.2017 | ||
| 520 | |a The HIV Prevention Trials Network (HPTN) 052 study, which showed the effectiveness of antiretroviral treatment in reducing HIV transmission, has been hailed as a “game changer” in the fight against HIV, prompting calls for scaling up treatment as prevention (TasP). However, it is unclear how TasP can be financed, given flat-lining support for global HIV programs. We assess whether TasP is indeed a game changer or if comparable benefits are obtainable at similar or lower cost by increasing coverage of medical male circumcision (MMC) and antiretroviral treatment (ART) at CD4 <350/μL. We develop a new mathematical model and apply it to South Africa, finding that high ART coverage combined with high MMC coverage provides approximately the same HIV incidence reduction as TasP, for |5 billion less over 2009-2020. MMC outperforms ART significantly in cost per infection averted ($1,096 vs. $6,790) and performs comparably in cost per death averted ($5,198 vs. $5,604). TasP is substantially less cost effective at $8,375 per infection and $7,739 per death averted. The prevention benefits of HIV treatment are largely reaped with high ART coverage. The most cost-effective HIV prevention strategy is to expand MMC coverage and then scale up ART, but the most cost-effective HIV-mortality reduction strategy is to scale up MMC and ART jointly. TasP is cost effective by commonly used absolute benchmarks but it is far less cost effective than MMC and ART. Given South Africa’s current annual ART spending, the |5 billion in savings offered by MMC and ART over TasP in the next decade, for similar health benefits, challenges the widely hailed status of TasP as a game changer. | ||
| 700 | 1 | |a Bloom, David E. |d 1955- |e VerfasserIn |0 (DE-588)129360104 |0 (DE-627)393622622 |0 (DE-576)297618717 |4 aut | |
| 700 | 1 | |a Humair, Salal |e VerfasserIn |0 (DE-588)1133082866 |0 (DE-627)888222998 |0 (DE-576)489096441 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |a National Academy of Sciences (Washington, DC) |t Proceedings of the National Academy of Sciences of the United States of America |d Washington, DC : National Acad. of Sciences, 1915 |g 109(2012), 52, Seite 21271-21276 |h Online-Ressource |w (DE-627)254235379 |w (DE-600)1461794-8 |w (DE-576)073260509 |x 1091-6490 |7 nnas |
| 773 | 1 | 8 | |g volume:109 |g year:2012 |g number:52 |g pages:21271-21276 |g extent:6 |a Economics of antiretroviral treatment vs. circumcision for HIV prevention |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1073/pnas.1209017110 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://www.pnas.org/doi/full/10.1073/pnas.1209017110 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20170530 | ||
| 993 | |a Article | ||
| 994 | |a 2012 | ||
| 998 | |g 120262029 |a Bärnighausen, Till |m 120262029:Bärnighausen, Till |p 1 |x j | ||
| 999 | |a KXP-PPN1559096527 |e 2970420287 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"id":{"eki":["1559096527"],"doi":["10.1073/pnas.1209017110"]},"note":["Gesehen am 30.05.2017"],"physDesc":[{"extent":"6 S."}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"person":[{"display":"Bärnighausen, Till","given":"Till","family":"Bärnighausen","role":"aut","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","role":"aut","family":"Bloom","given":"David E.","display":"Bloom, David E."},{"roleDisplay":"VerfasserIn","role":"aut","given":"Salal","family":"Humair","display":"Humair, Salal"}],"relHost":[{"note":["Gesehen am 09.03.2022"],"titleAlt":[{"title":"PNAS online"},{"title":"PNAS"}],"pubHistory":["1.1915 -"],"physDesc":[{"extent":"Online-Ressource"}],"id":{"eki":["254235379"],"issn":["1091-6490"],"zdb":["1461794-8"]},"corporate":[{"role":"aut","roleDisplay":"VerfasserIn","display":"National Academy of Sciences"}],"part":{"pages":"21271-21276","year":"2012","volume":"109","text":"109(2012), 52, Seite 21271-21276","extent":"6","issue":"52"},"disp":"National Academy of Sciences (Washington, DC)Proceedings of the National Academy of Sciences of the United States of America","title":[{"title":"Proceedings of the National Academy of Sciences of the United States of America","title_sort":"Proceedings of the National Academy of Sciences of the United States of America"}],"origin":[{"dateIssuedDisp":"1915-","publisher":"National Acad. of Sciences","publisherPlace":"Washington, DC","dateIssuedKey":"1915"}],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"recId":"254235379"}],"name":{"displayForm":["Till Bärnighausen, David E. Bloom, and Salal Humair"]},"recId":"1559096527","title":[{"title_sort":"Economics of antiretroviral treatment vs. circumcision for HIV prevention","title":"Economics of antiretroviral treatment vs. circumcision for HIV prevention"}],"language":["eng"],"origin":[{"dateIssuedKey":"2012","dateIssuedDisp":"December 26, 2012"}]} | ||
| SRT | |a BAERNIGHAUECONOMICSO2620 | ||